Timothy Hester is a partner who concentrates in the field of antitrust litigation and antitrust counseling matters. In recent years, he has handled a series of major antitrust litigation projects in the pharmaceutical industry, including the defense of antitrust suits raising claims of sham litigation, wrongful patent acquisitions, and unlawful patent settlements. Other antitrust litigation he has handled in recent years included a challenge to industry standards-setting, the defense of antitrust claims against Procter & Gamble challenging the settlement of patent litigation, and the defense of antitrust claims against the National Football League related to satellite television programming. Beyond these matters, he has been involved in a series of civil and criminal antitrust matters involving conspiracy claims and monopolization theories across a range of industries and products over roughly 20 years.
Aside from his work in antitrust litigation, Mr. Hester has an active antitrust counseling practice that includes, in particular, merger reviews, merger clearances under Hart-Scott-Rodino and foreign notification requirements, acquisitions and joint ventures, patent-antitrust matters, conspiracy investigations, and distribution agreements. He has represented clients in merger reviews and investigatory matters before both the Justice Department and FTC, and was deeply involved in representing Exxon before the FTC in the Exxon-Mobil merger. He has also handled litigation and merger matters before regulatory agencies, including the Surface Transportation Board, the Department of Transportation, and the Copyright Office.
Mr. Hester is the chair of the firm’s Management and Executive Committees.
Honors and Rankings
- LMG Life Sciences, "Life Science Star" (2013)
- Mr. Hester has been involved for over 20 years in pro bono death penalty litigation, including cases in Alabama, Florida, Mississippi, and Virginia.
Publications and Speeches